Allied Corp. (ALID)
- Previous Close
0.1552 - Open
0.1620 - Bid --
- Ask --
- Day's Range
0.1450 - 0.1620 - 52 Week Range
0.0211 - 0.3171 - Volume
3,100 - Avg. Volume
15,537 - Market Cap (intraday)
17.142M - Beta (5Y Monthly) -0.04
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Allied Corp., a cannabis company, engages in the research, development, and production of cannabinoid health solutions in the United States. The company offers hemp derived CBD natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummies under the Tactical Relief brand. It also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post activity rub for aches and pains; and Quick Hit, a CBD gummies with vitamin B12 under the Equilibrium Bio brand. In addition, the company offers Skin Structure, a facial formula applied to enhance skin; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds for areas with inflammation, pain, and other skin ailments under the MaXXa brand. Further, it is developing ALID 10 and ALID 11, which is in Phase I clinical trial a pharma product for the treatment of post-traumatic stress disorder and related mental health conditions. The company is headquartered in Kelowna, Canada.
allied.health--
Full Time Employees
August 31
Fiscal Year Ends
Sector
Recent News: ALID
Performance Overview: ALID
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALID
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALID
Valuation Measures
Market Cap
17.14M
Enterprise Value
23.29M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
757.92
Price/Book (mrq)
--
Enterprise Value/Revenue
1.08k
Enterprise Value/EBITDA
-2.92
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-119.63%
Return on Equity (ttm)
--
Revenue (ttm)
21.51k
Net Income Avi to Common (ttm)
-9M
Diluted EPS (ttm)
-0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
101.65k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.2M
Company Insights: ALID
ALID does not have Company Insights